Skip to content

Rosuvastatin

Rosuvastatin is a statin that reduces cholesterol production by inhibiting HMG-CoA reductase. The catalogue represents it both as the sole active ingredient in Crestor and as one component of Roszet with ezetimibe.

Crestor

Hypercholesterolaemia

5mg · 10mg · 20mg

Utilised to manage lipid concentrations to alleviate arterial plaque risk and support hepatic cholesterol regulation.

From$1.05/ tabletView

Roszet

Primary Hyperlipidaemia

40mg + 10mg

Designed to support dual lipid reduction to manage hypercholesterolaemia and target arterial plaque risk.

From$4.58/ tabletView

Key points

  • Rosuvastatin is an HMG-CoA reductase inhibitor used to reduce LDL cholesterol.
  • Crestor contains rosuvastatin alone, while Roszet combines rosuvastatin with ezetimibe.
  • Muscle symptoms and liver effects are material safety topics in rosuvastatin product information.

Two attached medicine identities

Crestor presents rosuvastatin as the only active ingredient. Roszet has a two-part identity: rosuvastatin reduces hepatic cholesterol synthesis, while ezetimibe limits intestinal cholesterol absorption. The combination name therefore identifies both ingredients rather than a different name for rosuvastatin alone.

Why the statin identity matters

The records connect rosuvastatin with hypercholesterolaemia in the cholesterol management category. Official information also highlights muscle injury and liver effects as medicine-specific safety considerations, particularly when symptoms or interacting medicines change the clinical picture.

Further reading